In summary, our cross-sectional study demonstrates that APOE genetic polymorphisms, particularly ε4-containing genotypes, are significantly associated with higher odds of DPN in this hospital-based T2DM cohort, particularly in relation to lipid abnormalities. This evidence concerns the gene APOE and type 2 diabetes mellitus.